Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 266

1.

Furosemide stress test and interstitial fibrosis in kidney biopsies in chronic kidney disease.

Rivero J, Rodríguez F, Soto V, Macedo E, Chawla LS, Mehta RL, Vaingankar S, Garimella PS, Garza C, Madero M.

BMC Nephrol. 2020 Mar 6;21(1):87. doi: 10.1186/s12882-020-01721-z.

2.

A systematic review and meta-analysis of acute kidney injury in the intensive care units of developed and developing countries.

Melo FAF, Macedo E, Fonseca Bezerra AC, Melo WAL, Mehta RL, Burdmann EA, Zanetta DMT.

PLoS One. 2020 Jan 17;15(1):e0226325. doi: 10.1371/journal.pone.0226325. eCollection 2020.

3.

Community Health Care Quality Standards to Prevent Acute Kidney Injury and Its Consequences.

Silver SA, Nadim MK, O'Donoghue DJ, Wilson FP, Kellum JA, Mehta RL, Ronco C, Kashani K, Rosner MH, Haase M, Lewington AJP.

Am J Med. 2019 Dec 10. pii: S0002-9343(19)31081-2. doi: 10.1016/j.amjmed.2019.10.038. [Epub ahead of print] Review.

PMID:
31830434
4.

HIV RNA, CD4+ Percentage, and Risk of Hepatocellular Carcinoma by Cirrhosis Status.

Torgersen J, Kallan MJ, Carbonari DM, Park LS, Mehta RL, D'Addeo K, Tate JP, Lim JK, Goetz MB, Rodriguez-Barradas MC, Gibert CL, Bräu N, Brown ST, Roy JA, Taddei TH, Justice AC, Re VL.

J Natl Cancer Inst. 2019 Nov 5. pii: djz214. doi: 10.1093/jnci/djz214. [Epub ahead of print]

PMID:
31687755
5.

Changing Paradigms in Acute Kidney Injury: From Mechanisms to Management: Proceedings of the 9th Annual UAB-UCSD O'Brien Center Symposium.

Andringa KK, Mehta RL, Sanders PW, Agarwal A.

Nephron. 2019;143(3):153. doi: 10.1159/000503790. Epub 2019 Oct 8. No abstract available.

6.

International Society of Nephrology 0 by 25 Project: Lessons Learned.

Macedo E, Garcia-Garcia G, Mehta RL, Rocco MV.

Ann Nutr Metab. 2019;74 Suppl 3:45-50. doi: 10.1159/000500345. Epub 2019 Jun 14.

7.

Identification of Maltase Glucoamylase as a Biomarker of Acute Kidney Injury in Patients with Cirrhosis.

Awdishu L, Tsunoda S, Pearlman M, Kokoy-Mondragon C, Ghassemian M, Naviaux RK, Patton HM, Mehta RL, Vijay B, RamachandraRao SP.

Crit Care Res Pract. 2019 Apr 16;2019:5912804. doi: 10.1155/2019/5912804. eCollection 2019.

8.

Angiogenesis Markers and Recovery From Acute Kidney Injury: A Piece of the Puzzle?

Bouchard J, Mehta RL.

Am J Kidney Dis. 2019 Jul;74(1):12-14. doi: 10.1053/j.ajkd.2019.03.421. Epub 2019 May 15. No abstract available.

PMID:
31103333
9.

Quality Improvement Goals for Acute Kidney Injury.

Kashani K, Rosner MH, Haase M, Lewington AJP, O'Donoghue DJ, Wilson FP, Nadim MK, Silver SA, Zarbock A, Ostermann M, Mehta RL, Kane-Gill SL, Ding X, Pickkers P, Bihorac A, Siew ED, Barreto EF, Macedo E, Kellum JA, Palevsky PM, Tolwani AJ, Ronco C, Juncos LA, Rewa OG, Bagshaw SM, Mottes TA, Koyner JL, Liu KD, Forni LG, Heung M, Wu VC.

Clin J Am Soc Nephrol. 2019 Jun 7;14(6):941-953. doi: 10.2215/CJN.01250119. Epub 2019 May 17.

PMID:
31101671
10.

Does acute kidney disease following primary percutaneous coronary intervention lead to chronic kidney disease development and progression?

Macedo E, Mehta RL.

Coron Artery Dis. 2019 Mar;30(2):93-94. doi: 10.1097/MCA.0000000000000713. No abstract available.

11.

Recurrent Acute Kidney Injury: Can We Differentiate From Nonrecovery and CKD Progression?

Macedo E, Mehta RL.

Am J Kidney Dis. 2019 Feb;73(2):150-152. doi: 10.1053/j.ajkd.2018.10.002. Epub 2018 Dec 12. No abstract available.

PMID:
30551895
12.

Timing of Kidney Replacement Therapy in Acute Kidney Injury.

Zarbock A, Mehta RL.

Clin J Am Soc Nephrol. 2019 Jan 7;14(1):147-149. doi: 10.2215/CJN.08810718. Epub 2018 Nov 30. No abstract available.

13.

Effect of Human Recombinant Alkaline Phosphatase on 7-Day Creatinine Clearance in Patients With Sepsis-Associated Acute Kidney Injury: A Randomized Clinical Trial.

Pickkers P, Mehta RL, Murray PT, Joannidis M, Molitoris BA, Kellum JA, Bachler M, Hoste EAJ, Hoiting O, Krell K, Ostermann M, Rozendaal W, Valkonen M, Brealey D, Beishuizen A, Meziani F, Murugan R, de Geus H, Payen D, van den Berg E, Arend J; STOP-AKI Investigators.

JAMA. 2018 Nov 20;320(19):1998-2009. doi: 10.1001/jama.2018.14283.

14.

Prevalence of peripapillary choroidal neovascular membranes (PPCNV) in an elderly UK population-the Bridlington eye assessment project (BEAP): a cross-sectional study (2002-2006).

Wilde C, Poostchi A, Mehta RL, Hillman JG, MacNab HK, Messina M, Monaco G, Vernon SA, Amoaku WM.

Eye (Lond). 2019 Mar;33(3):451-458. doi: 10.1038/s41433-018-0232-y. Epub 2018 Oct 12.

15.

Changing Paradigms in Acute Kidney Injury: From Mechanisms to Management: Proceedings of the 8th Annual UAB-UCSD O'Brien Center Symposium.

Andringa KK, Mehta RL, Sanders PW, Agarwal A.

Nephron. 2018;140(2):79-80. doi: 10.1159/000492947. Epub 2018 Sep 10. No abstract available.

16.

Risk of renal events following intravenous iodinated contrast material administration among inpatients admitted with cancer a retrospective hospital claims analysis.

Ng CS, Kalva SP, Gunnarsson C, Ryan MP, Baker ER, Mehta RL.

Cancer Imaging. 2018 Aug 24;18(1):30. doi: 10.1186/s40644-018-0159-3.

17.

Use of Estimating Equations for Dosing Antimicrobials in Patients with Acute Kidney Injury Not Receiving Renal Replacement Therapy.

Awdishu L, Connor AI, Bouchard J, Macedo E, Chertow GM, Mehta RL.

J Clin Med. 2018 Aug 11;7(8). pii: E211. doi: 10.3390/jcm7080211.

18.

Cardiac and Vascular Surgery-Associated Acute Kidney Injury: The 20th International Consensus Conference of the ADQI (Acute Disease Quality Initiative) Group.

Nadim MK, Forni LG, Bihorac A, Hobson C, Koyner JL, Shaw A, Arnaoutakis GJ, Ding X, Engelman DT, Gasparovic H, Gasparovic V, Herzog CA, Kashani K, Katz N, Liu KD, Mehta RL, Ostermann M, Pannu N, Pickkers P, Price S, Ricci Z, Rich JB, Sajja LR, Weaver FA, Zarbock A, Ronco C, Kellum JA.

J Am Heart Assoc. 2018 Jun 1;7(11). pii: e008834. doi: 10.1161/JAHA.118.008834. Review. No abstract available.

19.

Prevalence of reticular pseudodrusen in an elderly UK Caucasian population-The Bridlington Eye Assessment Project (BEAP): a cross-sectional study (2002-2006).

Wilde C, Poostchi A, Mehta RL, Hillman JG, MacNab HK, Messina M, Morales M, Vernon SA, Amoaku WM.

Eye (Lond). 2018 Jun;32(6):1130-1137. doi: 10.1038/s41433-018-0049-8. Epub 2018 Mar 1.

20.

Interpreting the Tinnitus Questionnaire (German version): what individual differences are clinically important?

Hall DA, Mehta RL, Argstatter H.

Int J Audiol. 2018 Jul;57(7):553-557. doi: 10.1080/14992027.2018.1442591. Epub 2018 Feb 28.

PMID:
29490515
21.

JAK1/JAK2 inhibition by baricitinib in diabetic kidney disease: results from a Phase 2 randomized controlled clinical trial.

Tuttle KR, Brosius FC 3rd, Adler SG, Kretzler M, Mehta RL, Tumlin JA, Tanaka Y, Haneda M, Liu J, Silk ME, Cardillo TE, Duffin KL, Haas JV, Macias WL, Nunes FP, Janes JM.

Nephrol Dial Transplant. 2018 Nov 1;33(11):1950-1959. doi: 10.1093/ndt/gfx377.

23.

Mice overexpressing chromogranin A display hypergranulogenic adrenal glands with attenuated ATP levels contributing to the hypertensive phenotype.

Mir SA, Li Y, Story JD, Bal S, Awdishu L, Street AA, Mehta RL, Singh P, Vaingankar SM.

J Hypertens. 2018 May;36(5):1115-1128. doi: 10.1097/HJH.0000000000001678.

24.

Changing Paradigms in Acute Kidney Injury: From Mechanisms to Management.

Mehta RL, Andringa KK, Sanders PW, Agarwal A.

Nephron. 2017;137(4):251-252. doi: 10.1159/000478056. Epub 2017 Nov 4. No abstract available.

25.

Mildly elevated lactate levels are associated with microcirculatory flow abnormalities and increased mortality: a microSOAP post hoc analysis.

Vellinga NAR, Boerma EC, Koopmans M, Donati A, Dubin A, Shapiro NI, Pearse RM, van der Voort PHJ, Dondorp AM, Bafi T, Fries M, Akarsu-Ayazoglu T, Pranskunas A, Hollenberg S, Balestra G, van Iterson M, Sadaka F, Minto G, Aypar U, Hurtado FJ, Martinelli G, Payen D, van Haren F, Holley A, Gomez H, Mehta RL, Rodriguez AH, Ruiz C, Canales HS, Duranteau J, Spronk PE, Jhanji S, Hubble S, Chierego M, Jung C, Martin D, Sorbara C, Bakker J, Ince C; microSOAP study group.

Crit Care. 2017 Oct 18;21(1):255. doi: 10.1186/s13054-017-1842-7.

26.

Allogeneic Mesenchymal Stem Cells for Treatment of AKI after Cardiac Surgery.

Swaminathan M, Stafford-Smith M, Chertow GM, Warnock DG, Paragamian V, Brenner RM, Lellouche F, Fox-Robichaud A, Atta MG, Melby S, Mehta RL, Wald R, Verma S, Mazer CD; ACT-AKI investigators.

J Am Soc Nephrol. 2018 Jan;29(1):260-267. doi: 10.1681/ASN.2016101150. Epub 2017 Oct 16.

27.

Assessing the impact of the introduction of an electronic hospital discharge system on the completeness and timeliness of discharge communication: a before and after study.

Mehta RL, Baxendale B, Roth K, Caswell V, Le Jeune I, Hawkins J, Zedan H, Avery AJ.

BMC Health Serv Res. 2017 Sep 5;17(1):624. doi: 10.1186/s12913-017-2579-3.

29.

Acute kidney injury in the ICU: from injury to recovery: reports from the 5th Paris International Conference.

Bellomo R, Ronco C, Mehta RL, Asfar P, Boisramé-Helms J, Darmon M, Diehl JL, Duranteau J, Hoste EAJ, Olivier JB, Legrand M, Lerolle N, Malbrain MLNG, Mårtensson J, Oudemans-van Straaten HM, Parienti JJ, Payen D, Perinel S, Peters E, Pickkers P, Rondeau E, Schetz M, Vinsonneau C, Wendon J, Zhang L, Laterre PF.

Ann Intensive Care. 2017 Dec;7(1):49. doi: 10.1186/s13613-017-0260-y. Epub 2017 May 4. Review.

30.

Moderator's view: Patient-centered approaches for optimizing AKI management: the role of kidney biomarkers.

Mehta RL.

Nephrol Dial Transplant. 2017 Mar 1;32(3):419-422. doi: 10.1093/ndt/gfx023. Review.

PMID:
28375506
31.

The 6R's of drug induced nephrotoxicity.

Awdishu L, Mehta RL.

BMC Nephrol. 2017 Apr 3;18(1):124. doi: 10.1186/s12882-017-0536-3. Review.

32.

Prevalence of age-related macular degeneration in an elderly UK Caucasian population-The Bridlington Eye Assessment Project: a cross-sectional study.

Wilde C, Poostchi A, Mehta RL, MacNab HK, Hillman JG, Vernon SA, Amoaku WM.

Eye (Lond). 2017 Jul;31(7):1042-1050. doi: 10.1038/eye.2017.30. Epub 2017 Mar 10.

33.

Guiding Physician Decisions for Initiating Dialysis for AKI: Is Progress on the Horizon?

Macedo E, Mehta RL.

Clin J Am Soc Nephrol. 2017 Feb 7;12(2):217-219. doi: 10.2215/CJN.00020117. Epub 2017 Jan 24. No abstract available.

34.

Critical care nephrology in 2016: Managing organ dysfunction in critical care.

Mehta RL.

Nat Rev Nephrol. 2017 Jan 19;13(2):71-72. doi: 10.1038/nrneph.2016.193. Review. No abstract available.

PMID:
28100907
35.

Acute Kidney Injury in Western Countries.

Bouchard J, Mehta RL.

Kidney Dis (Basel). 2016 Oct;2(3):103-110. Epub 2016 Mar 30. Review.

36.

Changing Paradigms in Acute Kidney Injury: From Mechanisms to Management.

Mehta RL, Andringa KK, Sanders PW, Agarwal A.

Nephron. 2016;134(3):131-132. Epub 2016 Sep 7. No abstract available.

37.

Serum Creatinine Trajectories for Community- versus Hospital-Acquired Acute Kidney Injury.

Warnock DG, Powell TC, Siew ED, Donnelly JP, Wang HE, Mehta RL.

Nephron. 2016;134(3):177-182. Epub 2016 Jul 26.

38.

Nomenclature for renal replacement therapy in acute kidney injury: basic principles.

Neri M, Villa G, Garzotto F, Bagshaw S, Bellomo R, Cerda J, Ferrari F, Guggia S, Joannidis M, Kellum J, Kim JC, Mehta RL, Ricci Z, Trevisani A, Marafon S, Clark WR, Vincent JL, Ronco C; Nomenclature Standardization Initiative (NSI) alliance.

Crit Care. 2016 Oct 10;20(1):318. Review.

39.

Study protocol for a multicentre randomised controlled trial: Safety, Tolerability, efficacy and quality of life Of a human recombinant alkaline Phosphatase in patients with sepsis-associated Acute Kidney Injury (STOP-AKI).

Peters E, Mehta RL, Murray PT, Hummel J, Joannidis M, Kellum JA, Arend J, Pickkers P.

BMJ Open. 2016 Sep 27;6(9):e012371. doi: 10.1136/bmjopen-2016-012371.

40.

Precision Fluid Management in Continuous Renal Replacement Therapy.

Murugan R, Hoste E, Mehta RL, Samoni S, Ding X, Rosner MH, Kellum JA, Ronco C; Acute Disease Quality Initiative (ADQI) Consensus Group.

Blood Purif. 2016;42(3):266-78. doi: 10.1159/000448528. Epub 2016 Aug 26. Review.

41.

Rationale and Design of the Genetic Contribution to Drug Induced Renal Injury (DIRECT) Study.

Awdishu L, Nievergelt CM, Davenport A, Murray PT, Macedo E, Cerda J, Chakaravarthi R, Ramachandra Rao SP, Holden A, Goldstein SL, Mehta RL.

Kidney Int Rep. 2016 Aug 24;1(4):288-298. doi: 10.1016/j.ekir.2016.08.010. eCollection 2016 Nov.

42.

ABT-719 for the Prevention of Acute Kidney Injury in Patients Undergoing High-Risk Cardiac Surgery: A Randomized Phase 2b Clinical Trial.

McCullough PA, Bennett-Guerrero E, Chawla LS, Beaver T, Mehta RL, Molitoris BA, Eldred A, Ball G, Lee HJ, Houser MT, Khan S.

J Am Heart Assoc. 2016 Aug 20;5(8). pii: e003549. doi: 10.1161/JAHA.116.003549.

43.

Fluid overload in the ICU: evaluation and management.

Claure-Del Granado R, Mehta RL.

BMC Nephrol. 2016 Aug 2;17(1):109. doi: 10.1186/s12882-016-0323-6. Review.

44.

Metabolic Profiling of Impaired Cognitive Function in Patients Receiving Dialysis.

Kurella Tamura M, Chertow GM, Depner TA, Nissenson AR, Schiller B, Mehta RL, Liu S, Sirich TL; FHN Study.

J Am Soc Nephrol. 2016 Dec;27(12):3780-3787. Epub 2016 Jul 21.

45.

Systematic review of outcome domains and instruments used in clinical trials of tinnitus treatments in adults.

Hall DA, Haider H, Szczepek AJ, Lau P, Rabau S, Jones-Diette J, Londero A, Edvall NK, Cederroth CR, Mielczarek M, Fuller T, Batuecas-Caletrio A, Brueggemen P, Thompson DM, Norena A, Cima RF, Mehta RL, Mazurek B.

Trials. 2016 Jun 1;17(1):270. doi: 10.1186/s13063-016-1399-9. Review.

46.

Continuous Dialysis Therapies: Core Curriculum 2016.

Macedo E, Mehta RL.

Am J Kidney Dis. 2016 Oct;68(4):645-657. doi: 10.1053/j.ajkd.2016.03.427. Epub 2016 May 28. No abstract available.

PMID:
27241853
47.

Corrigendum to "Management of the critically ill patients with cirrhosis: A multidisciplinary perspective".

Nadim MK, Durand F, Kellum JA, Levitsky J, O'Leary JG, Karvellas CJ, Bajaj JS, Davenport A, Jalan R, Angeli P, Caldwell SH, Fernández J, Francoz C, Garcia-Tsao G, Ginès P, Ison MG, Kramer DJ, Mehta RL, Moreau R, Mulligan D, Olson JC, Pomfret EA, Senzolo M, Steadman RH, Subramanian RM, Vincent JL, Genyk YS.

J Hepatol. 2016 May 27. pii: S0168-8278(16)30185-4. doi: 10.1016/j.jhep.2016.05.001. [Epub ahead of print] No abstract available.

PMID:
27241199
48.

Renal-Replacement Therapy in the Critically Ill--Does Timing Matter?

Mehta RL.

N Engl J Med. 2016 Jul 14;375(2):175-6. doi: 10.1056/NEJMe1606125. Epub 2016 May 15. No abstract available.

PMID:
27181293
49.

Choosing which ear to implant in adult candidates with functional residual hearing.

Fielden CA, Mehta RL, Kitterick PT.

Cochlear Implants Int. 2016 Apr;17 Suppl 1:47-50. doi: 10.1080/14670100.2016.1155805.

PMID:
27099111
50.

Recognition and management of acute kidney injury in the International Society of Nephrology 0by25 Global Snapshot: a multinational cross-sectional study.

Mehta RL, Burdmann EA, Cerdá J, Feehally J, Finkelstein F, García-García G, Godin M, Jha V, Lameire NH, Levin NW, Lewington A, Lombardi R, Macedo E, Rocco M, Aronoff-Spencer E, Tonelli M, Zhang J, Remuzzi G.

Lancet. 2016 May 14;387(10032):2017-25. doi: 10.1016/S0140-6736(16)30240-9. Epub 2016 Apr 13. Erratum in: Lancet. 2016 May 14;387(10032):1998.

PMID:
27086173

Supplemental Content

Loading ...
Support Center